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Abstract
Background: Human embryonic stem cells (hESC) should enable novel insights into early human development and provide
a renewable source of cells for regenerative medicine. However, because the three-dimensional hESC aggregates [embryoid
bodies (hEB)] typically employed to reveal hESC developmental potential are heterogeneous and exhibit disorganized
differentiation, progress in hESC technology development has been hindered.
Methodology/Principal Findings: Using a centrifugal forced-aggregation strategy in combination with a novel centrifugal-
extraction approach as a foundation, we demonstrated that hESC input composition and inductive environment could be
manipulated to form large numbers of well-defined aggregates exhibiting multi-lineage differentiation and substantially
improved self-organization from single-cell suspensions. These aggregates exhibited coordinated bi-domain structures
including contiguous regions of extraembryonic endoderm- and epiblast-like tissue. A silicon wafer-based microfabrication
technology was used to generate surfaces that permit the production of hundreds to thousands of hEB per cm
2.
Conclusions/Significance: The mechanisms of early human embryogenesis are poorly understood. We report an ultra high
throughput (UHTP) approach for generating spatially and temporally synchronised hEB. Aggregates generated in this
manner exhibited aspects of peri-implantation tissue-level morphogenesis. These results should advance fundamental
studies into early human developmental processes, enable high-throughput screening strategies to identify conditions that
specify hESC-derived cells and tissues, and accelerate the pre-clinical evaluation of hESC-derived cells.
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Introduction
Early human embryogenesis is a complex and highly ordered
process. Specific genetic programs, activated in response to
positional and inter-cellular cues, initiate a cascade of develop-
mental trajectories wherein the progeny of single cells self-organize
into tissues and organs. After fertilization, the egg undergoes
several rounds of cell division to give rise to the morula. A radial
round of cell division then gives rise to the spatially distinct
trophectoderm and inner cell mass (ICM). This is followed by the
formation of a cavity – the blastocoel – within the structure, now
known as a blastocyst, with the ICM at one side. The primitive
endoderm then develops at the blastocoelic surface of the ICM,
and migrates out across the inner surface of the blastocoel. This
then differentiates to the parietal endoderm, which overlies the
trophectoderm, and the visceral endoderm (VE), which overlies
the ICM. As the VE lays down a basement membrane at the VE-
ICM interface, the ICM polarizes and gives rise to a pluripotent
epithelium known as the epiblast. This process is depicted in
Supplementary Figure S1, both morphologically and as a cellular
differentiation hierarchy. The epiblast tissue marks a critical
organizational step in the self-assembly of the embryo proper.
Subsequently, via a co-ordinated multi-cellular migration and
differentiation step known as gastrulation, the epiblast gives rise to
the three classical embryonic germ layers, ectoderm, endoderm
and mesoderm, from which all embryonic tissues derive. The
generation of specific functionally-appropriate cell types clustered
at particular locations, rather than scattered throughout the
developing embryo, is likely a result of both physical (cell adhesion
mediated) and biochemical (morphogen-mediated) signals [1–3].
The ability to recapitulate aspects of human developmental
processes in vitro using hESC[4] is of significant interest. From a
developmental biology perspective, direct observation and manip-
ulation of the earliest stages of mouse morphogenesis has proved
highly informative. In comparison, data on the earliest stages of
human development are (not surprisingly) rare and the ability to
study reported differences in mouse and human development[5] is
expected to be enlightening. From a tissue engineering[6]
perspective, appropriate spatial, temporal and mechanical cues
are likely to be necessary for differentiation of ESC-derived
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damaged or diseased tissue [2,3,7,8]. As it is the processes of
development that give rise to these tissues and organs in the first
place, these same processes are a logical place to turn in the search
for a means of repair or replacement [9]. Unfortunately,
application of this paradigm has been hampered by our
rudimentary understanding of human embryogenesis – itself a
product of the inaccessibility of this stage of development for both
practical and ethical reasons. There is thus a need for methods that
capture not merely the differentiation of individual stem cells, but
the three-dimensional and tissue-level contexts in which this
differentiation occurs [10].
In order to recapitulate some of the cues and context inherent to
in vivo development, many hESC differentiation protocols employ
3-dimensional aggregates known as embryoid bodies (hEB)[11] as
an inductive step. While hEB permit the generation of cells arising
from all three primary germ layers, in contrast to mouse EB [12–
16], hEB are commonly derived as a heterogeneous mixture by
scraping monolayer cultures to release colonies. This results in
hESC aggregate formation and subsequent differentiation which is
generally chaotic and disorganized, with wide variability both
between and within individual aggregates [11,17]. This inconsis-
tency imposes significant limitations on the use of hEB both as a
model system in which to study human development, and as a
source of differentiated cells for applications in both research and
clinical settings. In vivo, differentiation is not a cell-autonomous
process, instead being strongly dependant on the co-evolution of
the surrounding tissue [2,3,18–22], and the ability of the hEB to
meaningfully reflect this gestalt for studies of embryogenesis is thus
compromised. Similarly, attempts to direct differentiation along
specific trajectories via macro-environmental variables (i.e. growth
factors, medium formulations, etc.) for the purposes of regener-
ative medicine must compete with a wide range of uncharacterized
and potentially contradictory endogenous signals [23]. Conse-
quently, the precision of in vivo morphogenesis, where every cell
has its place, gives way to differentiation at the level of population
averages. The results are inefficiency and a contaminating
minefield of residual, potentially tumourigenic and inappropriately
differentiated cells [7,8,24].
Ideally then, an hEB-based hESC differentiation protocol
should have the following characteristics: 1) reproducibility – the
hEB generated should be consistent in size and shape, within and
between experiments; 2) symmetry – while current technology does
not permit total control over the micro-environment of each
individual cell, the production of hEB with maximal symmetry
would reduce the range of micro-environments present, simplifying
interactions with macro-environmental variables that are more
easily manipulated and providing a tabula rasa for intrinsic
organizational processes; 3) order – the hEB produced should
reflect the tissue-level organization of in vivo development
(facilitated by point 2); and 4) ease of use – the protocol should be
able to generate hundreds to thousands of hEB for further study
without being unduly labour-intensive. The desire to apply hEB
differentiation products in clinical-therapeutic and pharmaceuti-
cal-screening contexts adds a fifth target, scalability – that is, the
processes involved should permit a seamless transition of hEB
production across several orders of magnitude, from laboratory
observations to practical applications.
We have developed a hEB-generation system which fulfils these
requirements; we have used this technology to generate, in a
robust and scalable manner, morphologically organized aggregates
of hESC capable of multi-lineage differentiation. The tissue-level
organization we observe provides independent confirmation of the
recently reported non-clonal origin of hESC-derived structures
observed in teratomas [10], and will provide a solid foundation for
future investigations of the mechanisms of early morphogenesis
and development.
Results and Discussion
Micro-environment affects cell fate
When generated via commonly-employed scraping techniques
[11], hEB are extremely heterogeneous in size, shape and
organization (Figure 1A). In fact, despite common usage in the
hESC field, it is not clear that these objects actually merit the term
‘‘embryoid body’’, rather than simply ‘‘hESC aggregates’’. We
have thus restricted the use of the term ‘‘embryoid body’’ (EB) to
describe aggregates which display clear multi-cellular organiza-
tion, and use the term ‘‘aggregates’’ or ‘‘differentiating aggregates’’
for the typically-observed hESC-derived structures. This is
significant in that no two cells, whether within the same aggregate,
Figure 1. Conventional hESC differentiation protocols result in
heterogeneous aggregates with inconsistent organization and
structure: A. Conventional differentiating hESC aggregates, formed by
scraping colonies of hESC off the culture surface, are predominantly
disordered. As hESC colonies differ widely in size and shape, this
heterogeneity is passed on to the differentiating aggregate. Conse-
quently the local microenvironment is neither consistent between nor
within the aggregates. Scale bar represents 200 microns. Inset: Fusing
aggregates exhibit expression of the transcription factor CDX2 (green,
counterstain 7AAD, red) at points of contact, but not elsewhere,
demonstrating the ability of microenvironmental cues to override
macro-environmental conditions. Scale bar represents 200 microns. B–
D. Rare hESC-derived aggregates exhibit self-organization.
Within heterogeneous populations of scraped hESC-derived aggre-
gates, a rare subpopulation of hEB can be observed. These hEB are
characterized by the presence of two distinct domains, visible in phase
contrast (B). An inner domain is positive for the pluripotency marker
Oct4 (C/D – red), while the outer domain is positive for the endodermal
marker FoxA2 (shown in green in panel C). A laminin-containing
membrane at least partially defines the interface between these two
domains (shown in green in panel D, counterstained with Hoechst in
blue). Scale bars represent 100 microns.
doi:10.1371/journal.pone.0001565.g001
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same microenvironment. As one example, ESC aggregates are
prone to adhere to and fuse with one another [25], and we have
observed expression of the transcription factor Cdx2 – known to
play a significant role in cell fate decisions [26] – in a subset of cells
at the junction of fusing hESC aggregates (Figure 1A inset: green –
Cdx2, red – DNA), demonstrating that incidental differences in
micro-environment can override common macro-environmental
signals. Micro-environmental heterogeneity might also be expect-
ed to interfere with any intrinsic self-organizational capacity of
differentiating hESC. Human ESC-derived aggregate heteroge-
neity thus places significant limitations on their utility as tools to
understand development or control hESC differentiation.
Exploring the capacity of hESC to self-organize towards
hEB
Based on the substantial self-organization that pluripotent cells
undergo during normal (see Figure S1) and aberrant development,
and previous observations on the behaviour of murine and human
EB [27–29], we hypothesized that the ability to generate tissue-
level order is intrinsic to hESC; the reason it is rare in
conventional differentiation cultures is that the disorder and
irregularity characteristic of the aggregate-generation protocols
usually employed leaves only a few aggregates within the
homeostatic envelope where this level of organization is accessible.
Thus, if a strategy allowing for consistency in aggregate formation
could be developed, it should be possible to define conditions
which allow these aggregates to self-organize in a robust and
predictable manner.
Furthermore, while hESC aggregate formation is commonly
employed to induce hESC differentiation, comparatively little
attention has been focussed on tissue-level organization within the
differentiating aggregates, despite evidence of such potential in
murine EBs [30,31] (a few recent publications have reported the
presence of apparent VE at the surface of hEB generated via a
mechanical dissection technique [29,32]).
We thus first sought evidence of the capacity of hESC to give
rise to tissue-level organization. We employed commonly used
differentiation induction techniques (e.g. colony scraping), taking
advantage of the heterogeneity of aggregates produced in this
manner to broadly survey their capacity for self-organization. A
subpopulation (frequency varying between preparations but
generally in the range of a few percent of the total) exhibited a
multi-laminar radial organization, which was most pronounced
and symmetrical among aggregates of two- to three-hundred
microns diameter (Figure 1B). Preparations of scraped hESC
aggregates were fixed and subjected to immunofluorescent
staining, and imaged by fluorescence microscopy (Figure 1C and
D). Within the highly-organized subpopulation, distinct segrega-
tion into two domains was apparent. An inner domain consisted of
cells uniformly positive for the pluripotency marker Oct4, often
exhibiting columnar structure with nuclei at the basal surface and
formation of an inner cavity. In contrast, cells in the second
domain at the aggregate surface were positive for the endodermal
marker FoxA2. The interface between the two domains exhibited
regions of staining for the basement membrane protein laminin.
These results are reminiscent of the epiblast and visceral
endoderm domains of the developing embryo (Supplementary
Figure S1F), and suggest that hESC are capable of recapitulating
at least some aspects of the supra-cellular order that characterizes
in vivo development. The ability to generate distinct populations of
cells with little or no mixing is an important component of the
objective of efficient production of clinically useful cell types,
uncontaminated by potentially tumourigenic stem cells.
Forced aggregation of hESC single-cell suspension
Having established that hESC have the inherent capacity to give
rise to structured EB, we then proceeded to develop approaches that
would allow them to do so more efficiently. We had observed that
these organized structures generally formed from more symmetrical
aggregates, and within a certain size range, so we sought means of
more reliably producing this class of aggregates. More uniform
aggregates of mouse ESC are often generated from a single cell
suspension using the hanging drop method [12,13]. However, hESC
hanging-drop protocols appear to require small clumps of cells [33],
and we wished to minimize the variability and potential for multiple
organizing centres that might arise in this situation. The use of cell
clumps rather than single cells as inputs would also introduce the
possibility of pre-existing organization, and thus complicate future
investigations of the process of self-organization within the resulting
aggregates. Finally, a single-cell based hEB protocol will simplify
studies on the effects of cell mixing on genetic manipulations of
hESC differentiation. Building on the hanging-drop concept, mEB
have also been generated from single cell suspensions of mESC in
microcentrifuge tubes [14], and in 96-well U-bottom microtiter
plates [16]. A recently published protocol extended this concept to
hESC [34], via the addition of a centrifugation step. While this
approach provided the benefits of homogenization of the starting
population, and consistent cell numbers between replicates, we
encountered difficulties in adapting this protocol to our needs. In
particular, we found the initial cell pellet formed in a disk
configuration, which then collapsed into one or more three-
dimensional structures over time, resulting in reduced initial
symmetry and more variable aggregate size. We also encountered
difficultiesinrobustlyextractingintactaggregatesfromthewellsafter
formation (see below).
Improving reliability, symmetry and throughput of
aggregate formation
In order to force immediate formation of a more compact pellet,
avoid the generation of multiple aggregates from a single well, and
increase throughput, we employed 96- and 384-well V-bottom
plates. As a metric of success in achieving reliable, consistent and
efficient incorporation of hESC into a single aggregate per well,
aggregate size (cross-sectional area) was monitored using light
microscopy under various conditions. To transition to a true high
throughput (HTP) process, we also sought a means of removing the
aggregates thus formed from the plates with minimal mechanical
disruption, in a manner compatible with automation. We therefore
manufactured centrifugation chambers capable of holding a
standard-format microtiter plate in an inverted configuration,
allowing us to extract the entire contents of several 384-well plates
simultaneously. We refer to the aggregates produced in this way as
‘‘Spin-In, Spin-Out Embryoid Bodies’’ (SISO-EB).
We initially observed significant variability in aggregate
formation efficacy between experiments, with nominally replicate
trials employing the same cell line and number of cells resulting in
coherent aggregate formation after 24 hours in one case, and then
failing do so in a subsequent attempt (data not shown). After
investigating potential causative factors, we noted that population
levels of the pluripotency marker Oct4 seemed to affect aggregate
cohesion, with aggregates formed from populations of cells with
the highest levels of Oct4 exhibiting the least stability. We thus
tested whether differentiation induction using serum-containing
medium would improve aggregate stability. As shown in Figure 2A,
this approach was successful, with 72 hours of serum induction
resulting in a substantial increase in aggregate size and symmetry.
hEB yield via this process approaches 100% (one aggregate per
well). The introduction of a spin-out step usable in 384-well format
UHTP Production of Ordered hEB
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resulted in a dramatic increase in the numbers of hEB that can be
efficiently generated. In combination with a basic liquid dispensing
system, we have been able to easily generate several thousand
organized hEB in a single experiment; we expect this HTP
approach to be limited only by the available liquid-handling
technology. The use of steeper well geometries (96- and 384-well
V-bottom plates, vs the 96-well U-bottom plates employed in the
original report [34]) also contributes to the direct formation of
single, symmetrical aggregates in each well.
We have also noted, anecdotally, that robust aggregate
formation can be influenced by other factors such as hESC
colony size and distribution on the culture surface, hESC passage
number, and protein inductive factors (data not shown). These
parameters, which may vary substantially between hESC cultures,
even within the same laboratory, may explain the problems we
initially encountered in generating ‘‘spin-EBs’’. In particular, it is
interesting that the hESC cultures usually considered to be of
highest quality (i.e. uniformly high Oct4 expression) may be less
well suited to aggregate formation. Consistent with this we have
recently reported that spatial distribution and local cell density-
mediated effects influence endogenous and exogenous signalling to
regulate hESC propagation [35]. Thus passaging frequency and
methodology are expected to affect hESC culture properties in a
manner that would impact spin-EB formation, likely a relevant
factor in previously published spin-EB protocols [34,36].
Figure 2. Controlling aggregate formation and stability: A. Pre-differentiation improves aggregate formation and stability. hESC
cultured on mouse embryonic fibroblast (MEF) feeders were pre-differentiated with 20% serum for 72 hours prior to aggregate formation, resulting
an overall reduction in the population level of Oct4 expression [left panel, red line: standard maintenance culture; blue line: pre-differentiated; black:
control (unstained)]. Aggregates formed from 2,000 input cells were substantially larger with treatment (blue bar) than without (red bar). Y axis
represents aggregate cross-sectional area in microns
2, error bars represent one standard deviation. B. The ROCK inhibitor Y-27632 promotes
aggregate stability. hESC cells cultured on Matrigel in MEF-conditioned medium with and without pre-differentiation [left panel, red line: standard
maintenance culture; blue line: pre-differentiated; black: control (unstained)] were used to form SISO-aggregates in the presence or absence of 10 mM
Y-27632. Under these culture conditions, in the absence of both, no aggregates were formed (N.D. - size not determined). With 48 hours pre-
differentiation in 20% serum, consistent aggregates were formed (first blue bar). When Y-27632 was added to the suspension of cells without (red
bar) or with (second blue bar) pre-differentiation immediately prior to dispensing into the well plate, sizeable aggregates resulted.
doi:10.1371/journal.pone.0001565.g002
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inhibitor Y-27632 has been reported to promote the survival of
hESC after dissociation to single cells, without affecting pluripotency
[37]. We therefore tested aggregate formation from 2,000 hESC
grown on Matrigel in conditioned medium, with and without
48 hours pre-differentiation and/or exposure to 10 mM Y-27632
during aggregation. Aggregates were spun out the following day,
captured on a 40 mm filter, resuspended and imaged. No aggregates
were observed in the absence of both pre-differentiation and Y-
27632, however either of these alone or in combination resulted in
aggregate formation, with the largest aggregates formed in the
presence of Y-27632 (Figure 2B). This approach provides a useful
alternative to the pre-differentiation technique, and allows investi-
gation into the mechanism-of-action of ROCK inhibition and its use
in bioprocesses for generating ESC-derived cells.
Controlling aggregate size
Having established a robust protocol for hEB formation in a
defined medium formulation, we sought to quantify our ability to
regulate aggregate size. Aggregates were formed in 384-well plates
from 400, 2,000 and 10,000 cells per well, and spun out after 24 h.
Cross-sectional area data was collected via phase-contrast
microscopy, and quantified using the ImageJ software package.
The improvement in aggregate consistency and size control over
conventional scraping techniques is striking (Figure 3), with
coefficients of variation of less than 0.1 for all three SISO
aggregate sizes, compared to .0.7 for the scraped hEB. From
previously published work [34] and our own investigations (data
not shown), hEB size plays a significant role in establishing
differentiation outcomes; thus the ability to control this parameter
is important to fundamental and applied applications.
Micro-textured surfaces for the scalable generation of
size-specified organized hEB
While the HTP combination of 384-well plates, automated liquid
handling, and a spin-out step allows a significant increase in
productivity over the current state-of-the-art, future bioreactor[38]
and high-throughput screening (HTS)[39,40] applications will
require further increases in throughput. Successful clinical applica-
tion of the differentiated progeny of hESC will require methods that
bridge the scale gap between the ability to produce thousands or
millions of cells at the laboratory bench, and the much larger
numbers that will be required per patient for clinical protocols (for
example a single bone marrow transplant may require hundreds of
millions of CD34+ cells [41], while cardiac therapies may require
replacement of the billion or more cardiomyocytes lost to an infarct
[42]). We thus set out to generate a cost-effective ultra-high
throughput (UHTP) method capable of meeting these requirements.
To accomplish this goal, we have used a novel approach to
generate textured surfaces consisting of numerous collecting
volumes, or micro-wells, at the base of a single common liquid
volume. Our design parameters included angled collecting surfaces
slopedtowardsacommoncollectingpoint,completesurfacetiling(to
avoid interference and inefficiencies arising from cells landing in the
dead space between micro-wells), and biocompatibility. Microfab-
rication of a master mold, followed by replica molding in
poly(dimethylsiloxane) (PDMS) is a technique capable of duplicating
extremelyfine features[43].PDMSreplicamoldinghasbeenusedto
cast arrays of widely spaced vertical-walled micro-wells for ESC
culture from templates generated via soft-lithographic techniques
[44,45]. Importantly however, soft lithography is not well suited to
the generation of the angled collecting surfaces required for this
application, and the use of vertical sidewalls also places mechanical-
strength limitations on how closely wells can be spaced. We took
advantage of the susceptibility of crystalline silicon to anisotropic
etching[46] to generate square-pyramidal pits inthe surface of a 1-0-
0 silicon wafer. As a result of the orientation-specific resistance of
internal crystal planes to the etchant, angled sidewalls of near
atomic-level perfection parallel to these planes are formed. These
sidewalls converge to a point if the etching is allowed to proceed to
completion; if the reaction is stopped before completion, a truncated
pyramidal well is formed. We then proceeded through two serial
roundsofPDMScasting,generatingfirstanegativecastofthesilicon
wafer, an array of pyramids, and then a positive cast from the
negative cast, replicating the array of micro-wells from the original
silicon wafer inbiocompatiblePDMS. Figure 4Adepictsa schematic
of this process, while panel B contains the corresponding
micrographs of the production of 800, 400, 200 and 100 micron
square micro-wells (yellow box denotes one square millimetre). The
upper row shows a top view of the silicon master, the middle row a
section through the PDMS negative casts, and the lower row a
section through the final PDMS wells (Figure 4A and B). Note that
the 800 micron wells were not etched to completion, demonstrating
a truncated pyramidalshape.Theapparentrounding of thepointsof
the smaller wells in the lateral sections is an artefact of imperfect
alignment between the well point and the plane of the cut.
Figure 3. SISO-aggregation allows for the generation of size-
controlled aggregates. (A) hEB were generated by scraping, and
SISO-aggregates were generated from input populations of 400, 2,000
and 10,000 cells in 384-well plates, and recovered by centrifugation.
After imaging in phase-contrast mode, images were thresholded and
cross-sectional areas were calculated using the ImageJ software
package. Values obtained were extremely consistent, with coefficients
of variation of 0.09, 0.06 and 0.08 respectively, vs 0.72 for the scraped
hEB. (B) The base-10 logarithm of cross sectional area is plotted on a
histogram, demonstrating the clear separation between aggregate sizes
and dramatic increase in size control over scraping techniques.
doi:10.1371/journal.pone.0001565.g003
UHTP Production of Ordered hEB
PLoS ONE | www.plosone.org 5 February 2008 | Volume 3 | Issue 2 | e1565We next tested the ability of these micro-wells to support hEB
formation. hESC cultured on MEF and predifferentiated in serum
for 48-hours were dissociated to single cells, and centrifuged onto
the micro-textured surfaces. After 24 hours, the micro-wells were
imaged, their contents extracted by pipetting, and additional
images were acquired. hEB formation and size control are clearly
preserved in this high-density format (Figure 4C). We also
validated the utility of these micro-wells in the context of ROCK
inhibition. For this study we extended our results to hESC cultured
on Matrigel in defined, serum-free medium [35,47]. Of note,
coherent aggregates generated under these conditions formed only
in the presence of Y-27632. Most significantly, in contrast to the
studies performed with pre-differentiated hESC in the absence of
Y-27632, centrifugal aggregation was not required for the
formation of hEB (Figure 4D). In this study the only xeno- and
undefined component in the generation of hEB is the Matrigel
upon which the hESC were cultured. ROCK inhibition is
similarly effective for hESC cultured on MEF (data not shown).
Our use ofmicro-textured surfaces allowsfor an additionalseveral
orders-of-magnitude increase in throughput over the gains arising
from the SISO-EB protocol. The approximately 100 cm
2 surface
area of a single standard well-plate footprint can accommodate
15,500, 62,500, 250,000 or 1,000,000 micro-wells of 800, 400, 200
or 100 micron size, respectively. As the textured surface is produced
via replica molding in PDMS at a cost of pennies per gram, much
larger total surface areas than this can be practically manufactured.
At the same time, tens to thousands of these same micro-wells can be
cast into much smaller surfaces, such as a single well in a 96-well
plate, for smaller scale investigations, or for high-throughput
screening. This potential for direct, effectively unlimited scalability
is expected to significantly accelerate clinical and pharmaceutical
applications of pluripotent cells by permitting promising basic-
researchobservationstobetranslatedintoaproductionenvironment
rapidly and efficiently, without the need to reformulate processes
using a different set of procedures.
Our results combining micro-textured surfaces with ROCK
inhibition establish further improvements (Figures 2B and 4D).
This approach has an advantage over serum-mediated pre-
differentiation in that Y-27632, being a small molecule, is a
defined xeno-free reagent. As the input cell suspension is generated
Figure 4. Micropatterned surfaces allow ultra-high-throughput (UHTP) production of size-specified aggregates. Surfaces patterned
with arrays of microwells were generated (A) in poly(dimethylsiloxane) via serial replica moulding from a pattern etched into a silicon wafer. Imaging
of the silicon master, the PDMS negative cast, and the PDMS positive cast show conservation of form across these steps with wells 100, 200, 400 and
800 microns square (B). Note that the 800 micron wells were generated in the form of a truncated pyramid. Dashed yellow square represents one
square millimeter. Sections of PDMS textured with 400 micron wells (C) were inserted into individual wells in a 24-well plate. A single-cell suspension
of hESC grown on MEF, predifferentiated with serum for 48 hours was dispensed into the well such that each microwell was predicted to capture the
desired number of cells. After 24 hours, the well contents were imaged, extracted, and re-imaged. Scale bar represents 400 microns. D.
Centrifugation is not required in the presence of ROCK inhibition. Cells grown on Matrigel in defined conditions were dispensed over the
microwells in the presence or absence of 10 mM of the ROCK inhibitor Y-27632. Aggregates formed only in the presence of 10 mM of the ROCK
inhibitor Y-27632, in the presence or absence of centrifugation. Scale bar represents 400 microns.
doi:10.1371/journal.pone.0001565.g004
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TM) medium formulation, there is no
additional requirement for xenobiotics or undefined components.
While we are presently undertaking molecular studies into the
effects of ROCK inhibition on hESC fate, published results[37]
have not detected effects on hEB lineage specification. Finally, the
ability to generate aggregates in this context without the
requirement for a centrifugation step renders the process
extremely simple, and easily implemented in an automated
manner. A laboratory-scale workstation with basic liquid and
plate handling capacity would be able to dispense hESC
suspensions into microtiter plates, incubate them, and recover
the aggregates with no operator intervention.
Human EB generated using scalable technologies exhibit
tissue-level organization
Having established methodologies to generate size-specified hEB
at very high frequencies (,100%), we proceeded to monitor the
structure of aggregates for several days following formation, in
order to determine the ability of aggregates formed via our
protocols to efficiently replicate the self-organization we noted in a
rare subpopulation of conventionally-formed aggregate cultures
(Figure 1B–D). Aggregates were formed from 2,000 cells, extracted
after 24 hours and imaged immediately (day 0) and daily for 4 days.
Note the appearance in Figure 5A of two distinct domains in the
phase contrast images by day 1 – a highly light-scattering,
apparently disordered domain, and a low light-scattering, appar-
ently more ordered domain. The ordered domain exhibits staining
for the pluripotency marker Oct4 (Figure 5B and C), while the
disordered domain exhibits staining for the endodermal markers
GATA-6[48,49] (Figure 5C and D), GATA4[50] (Figure 5D),
AFP[51] and FoxA2[52,53] (Figure 5E), and the primitive-
endoderm marker Sox7[54] (Figure 5F). FGF5, a marker
characteristic of epiblast and overlying VE [50,55], was detected
in both (Figure 5F). Indications of epithelial organization are seen
in regions where the ordered domain is only a single cell in
thickness, with an indication of columnar morphology, and basal
localization of nuclei over a laminin-containing basement mem-
brane (Figure 5B and C). These results indicate that SISO-EB self-
organize at frequencies approaching unity starting from a hESC
culture-derived single-cell suspension. The hEB thus formed
recapitulate at least some aspects of early embryogenesis and
differentiation, in a manner similar to the previously identified rare
EB subpopulation of conventional scraped hESC aggregates
(Figure 1B–D) albeit at a much greater efficiency (Figure 5A). Of
note, it has recently been reported that organized structures arising
from hESC in the context of teratomas are non-clonal in origin –
that is, order emerges via the coalescence of multiple cells, rather
than being inherited from a single progenitor [10]. In the context of
our single-cell-suspension-derived hEB, the rapidity with which
these structures form precludes the possibility that they are clonally
derived, providing independent confirmation of this observation in
an alternative system, and further emphasizing the importance of
micro-environment in determining differentiation trajectories.
The appearance of sharply demarcated spatial domains consisting
of distinct cell types within our hEB also represents a significant
advance. Whereas conventional hESC differentiation protocols are
able to produce various cell types, they have not been successful in
generating the tissue-level order and purity present in the structures
we have generated. Given that in vivo, the pluripotent epiblast gives
rise to the three canonical germ layers via organized tissue-level
movements, it is reasonable to expect that further refinements to this
protocol might render possible the organized and directed tissue-
level differentiation of morespecified tissue types.Suchprogress may
be a necessary step towards in vitro organogenesis.
hEB generated via our forced-aggregation techniques
can differentiate to cell types of clinical and scientific
interest
To ensure that our new protocols did not interfere with hESC
aggregate developmental potential, we next verified that our
methodology could be used to generate the specific differentiated
lineages typically derived from differentiated hESC aggregates.
Differentiated SISO-EB gave rise to beating cardiomyocytes
(Figure 6A and B), rosette-forming neural cells (Figure 6C), and
CD33
+ and CD45
+ cells and their associated blood-lineage
colony-forming cells (CFC) (Figure 6D–F). Quantitative RT-
PCR analysis of hEB formed from 10,000 pre-differentiated cells
in the absence of ROCK inhibition, differentiated for 4 days in
suspension followed by 3 days adherent culture, showed
upregulation of markers of endodermal, ectodermal and meso-
dermal lineages (Figure 6G) and concomitant reductions (relative
to input cells) in the expression of the pluripotency-associated
markers Oct4 and Nanog. In a complementary experiment, hEB
formed from 4,000 untreated cells in the presence of ROCK
inhibition, differentiated for 4 days in suspension, showed
upregulation of mesodermal and endodermal markers
(Figure 6H). While only a slight increase in levels of Sox7, a
marker characteristic of primitive endoderm [54], was observed,
much larger increases in other endodermal markers (GATA4,
FoxA2 and Sox17) were seen, suggesting the presence of definitive
endoderm. This is supported by increased levels of early
mesendoderm markers Brachyury and MixL1 indicating the
presence of precursor cell types.
The distinct differentiation trajectories observed under these two
conditions illustrate the potential for manipulation of output cell
populations by controlling the input population and/or the presence
of exogenous factors and interactions during hEB-mediated
differentiation. While the ‘‘default’’ (endogenous) differentiation
programs induce multiple lineages including extraembryonic
endoderm, by overriding endogenous signalling with exogenous
cytokinesandenvironments[56,57],weexpecttobeabletogenerate
relatively pure populations of various cell types. In preliminary
experiments, we have observed that sequential addition of specific
combinations of cytokines to hEB produced in the microwell device
can consistently give over 80% purity of a desired cell type (data not
shown). Given the substantially improved homogeneity of hEB
produced using our technology, this approach should allow for more
effective and higher throughput production of differentiated cells
than previously possible.
Summary
We present here methods for the production of hEB that fulfil
the criteria of reliability, symmetry, order, ease-of-use and scalability. Our
approach is well suited for substitution wherever more conven-
tional, less controlled aggregate-based hESC differentiation
induction protocols are currently employed. This technology is
also broadly applicable to aggregation of other cell types, including
pluripotent lines produced via recently reported iPS techniques
[58,59]. The single-cell suspension step integral to this protocol is
ideal for mixing experiments, and will also facilitate genetic
manipulation of the hESC. In addition to the common extant
applications of hEB, aggregates generated via these methods
exhibit consistent levels of symmetry and self-organization not
attainable using more traditional methods, laying the foundations
for a new paradigm of in vitro tissue-level differentiation. Finally,
the dramatic increase in hEB output achieved using these methods
now permits hEB-mediated differentiation applications not
previously attainable.
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Cell culture methods
Unless otherwise specified, hESC were cultured on an irradiated
mouse embryonic fibroblast (MEF) feeder layer as described
elsewhere [4], in KO-DMEM (Invitrogen, cat# 10829-018), 20%
KOSR (Invitrogen, cat# 10828-028,), 100 mM non-essential amino
acids (Invitrogen, cat# 11140-050), 2 mM Glutamax (Invitrogen,
cat# 35050-061),100 mMb-mercaptoethanol(Sigma-Aldrich,cat#
M7522) with 4 ng/mL FGF2 (Peprotech, cat# 100-18B). In some
cases, hESC were cultured on Matrigel (BD Biosciences, cat#
356231) coated (1:30 dilution) plasticware in either MEF-condi-
tioned medium with 12 ng/mL FGF2 (Peprotech, cat# 100-
18B)[60] or X-Vivo10
TM medium (BioWhittaker cat# 04-380Q)
with 20 ng/mL FGF2 (Peprotech, cat# 100-18B), 5 ng/mL Activin
A( R & Dc a t # 338-AC-025), and 0.1 ng/mL TGFb (R&D cat#
240-B-010) [35,47]. In all cases, efforts were made to ensure even
seeding of hESC across the well, relatively uniform colony size, and
anabsence oflarge clumps of cells.Experimentspresented here were
carried out in the H9 cell line; however the effectiveness of these
protocols for hESC aggregate formation was also confirmed in the
CA-1andI6celllines.RareorganizedhEBwerefirstobservedinthe
CA-1, CA-2 and H9 cell lines.
hEB formation by scraping
The method used to generate standard hEBs was based on
publishedprotocols[61].Briefly,hESCcolonieswereincubatedwith
0.1% Collagenase IV (Invitrogen, cat# 17104-019) at 37uCf o r
10 minutes.The CollagenaseIVwas removed and replaced with the
desired medium formulation. hESC colonies were scraped from the
tissue culture plastic using a cellscraper (Sarstedt, cat# 831830), and
Figure 5. SISO-EB are able to self-organize into highly ordered structures. A. Aggregates formed from 2,000 hESC, imaged immediately
after recovery (‘‘day 0’’)(Ai), or after 1, 2, 3 or 4 days respectively (Aii-Av). Note self organization into an ordered domain (white arrow) and a
disordered domain (black arrow), and progressive encirclement of the ordered domain by the disordered domain over time (red arrows). Scale bar
represents 500 microns. B. An aggregate fixed on day 3 of differentiation exhibits Oct4 positive nuclei (red) located basally within the cell over a
laminin-containing basement membrane (green) in the ordered domain, with morphologically distinct Oct4 negative cells located outside the
membrane in the disordered domain (counterstained with Hoechst, blue). Scale bar represents 50 microns. C. A day 5 aggregate exhibits staining for
the endodermal marker GATA-6 (green) in the encircling disordered domain, and the pluripotency marker Oct4 (red) within the ordered domain. Note
the tendancy of the Oct4 positive nuclei to align along the interface between the two tissue types, and a tendancy towards columnar morphology
(white arrow), both characteristics of epiblast tissue, and the absence of mixing between the two cell types. The actin cytoskeleton, probed with
phalloidin, is shown in blue. Scale bar represents 50 microns. D–F. Day 3 aggregates, showing staining for the endodermal markers GATA4, GATA6,
AFP and FoxA2, the primitive-endoderm marker Sox7, and FGF5, a marker characteristic of epiblast and overlying VE. Scale bars represent 50 microns.
doi:10.1371/journal.pone.0001565.g005
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PLoS ONE | www.plosone.org 8 February 2008 | Volume 3 | Issue 2 | e1565Figure 6. SISO-EB are able to give rise to cardiac, hematopoetic and neural cells. Cardiac differentiation from hEB differentiated for 12 days
in suspension culture in serum-containing medium. A) two frames from a video recording of a contractile aggregate, shown before (Ai) and during
(Aii) a contraction. Panel Aiii is derived by subtracting panel Ai from panel Aii. The contraction trace (B) was generated by integrating the subtraction
image derived from successive frames in the video over the area of contraction, and plotting a 5-point moving average. Neural rosettes (C) were
observed after 11 days in culture (4 days in suspension followed by 7 days adherent), staining positive for Pax6 (shown in green) and Sox2 (shown in
red). Hematopoetic differentiation was observed after 28 days using Cytospin (D), CFC (E) and flow cytometric (F) assays. G. Quantitative RT-PCR
results from aggregates formed from 10,000 pre-differentiated cells in the absence of ROCK inhibition, differentiated for 4 days in suspension
followed by an additional 3 days in adherent culture shows down-regulation of pluripotency genes, and up-regulation of markers for endodermal,
ectodermal and mesodermal lineages. H. Quantitative RT-PCR results from aggregates formed from 4,000 untreated cells in the presence of ROCK
inhibition, differentiated for 4 days in suspension, showed upregulation of mesodermal and endodermal markers, including markers for
mesendodermal precursors, but only limited upregulation of the primitive endoderm marker Sox7.
doi:10.1371/journal.pone.0001565.g006
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clumps of the desired size. These clumps were then transferred to an
ultra-low attachment non-tissue culture treated plate (Corning, cat#
3471) and cultured in suspension.
Flow cytometry for Oct4
Flow cytometric analysis for Oct4 expression was carried out as
described elsewhere [62]. In brief, hESC were fixed and permea-
bilized with an Intraprep Permeabilization Kit (Beckman Coulter,
cat# IM2389), and sequentially probed with primary antibody to
Oct3/4 (BD Transduction Laboratories, cat# 611202) and FITC
conjugated secondary antibody (Sigma-Aldrich, cat# F-2772), and
assayed on a Beckman Coulter Epics XL flow cytometer.
hESC preparation for aggregate formation
Prior to preparation of single-cell suspension, hESC were pre-
differentiated when specified by replacing the normal culture
medium with differentiation medium (DM – consisting of DMEM,
20% FCS, 1% NEAA, 1% beta-mercaptoethanol, 1% L-
glutamine, 0.5% Pen/Strep) for the specified time period
(generally 48 or 72 hours) prior to harvest. Cells were dissociated
with TrypLE
TM (Invitrogen, cat# 12605-028) for 3–10 minutes at
37uC, and optionally passed through a 40 micron filter unit. After
centrifugation, cells were resuspended at the desired concentration
in X-Vivo10
TM defined medium (BioWhittaker cat# 04-380Q).
Plate preparation for aggregate formation
96- or 384-well microtiter plates (Costar, cat# CS003896,
Whatman, cat# 7701-5101, lids cat# 7704-1001) were loaded
with 40 or 25 mL per well respectively of 5% (w/v) Pluronic F-127
(Sigma-Aldrich, cat# P2443) in PBS (Gibco, cat# 14190), and
incubated for at least 30 minutes at room temperature. Wells were
then emptied immediately prior to use.
Spin-in spin-out aggregate formation
Cells were loaded into plates prepared as above in 100 or 25 mL
volume for 96- and 384-well plates respectively. Plates were then
centrifuged for 5 minutes at 2006g, and then incubated overnight at
37uC, 5% CO2. The following day, well contents were recovered
either via inverted centrifugation in custom machined plate carriers
for1 minuteat506g,orpipettingwithlargebore‘‘genomic’’pipette
tips (Molecular Bioproducts, cat# 3531). The resulting aggregates
werethen optionally dispensed over aninverted 40 micron filter unit
to eliminate unincorporated cells and debris, and then washed off
and recovered. Aggregate size was assessed from calibrated
photomicrographs using the Analyze Particles function of the WCIF
ImageJ software package (http://rsb.info.nih.gov/ij/ and http://
www.uhnresearch.ca/facilities/wcif/fdownload.html).
hEB differentiation
hESC aggregates were cultured in suspension for 4 days in
hESC differentiation medium, containing KO-DMEM (Invitro-
gen, cat# 10829-018), 20% FBS (Gibco 12483-020), 100 mM non-
essential amino acids (Invitrogen, cat# 11140-050), 2 mM
Glutamax
TM (Invitrogen, cat# 35050-061), 100 mM b-mercapto-
ethanol (Sigma-Aldrich, cat# M7522), 1 U/mL penicillin and
1 mg/mL streptomycin (Invitrogen, cat# 15140-122), followed by
further suspension culture or by plating onto 0.5% gelatine coated
tissue culture treated dishes, and culture as EB outgrowths for the
remainder of differentiation culture. Cardiac differentiation was
detected as coordinated beating. Neural differentiation was
detected via the formation of neural rosettes.
For hematopoetic differentiation, hEB were cultured for 14 days
in differentiation medium with cytokines as described elsewhere
[63]. hEBs were then dissociated into single cells by trypsinization
(0.1% trypsin-EDTA) and filtration through 40 mm mesh to obtain
a uniform single cell suspension. 100,000 cells in 200 ml
differentiation medium were added to 2 ml methyl cellulose
medium supplemented with hematopoietic growth factors (Stem
Cell Technologies Inc., cat# H4435), plated in 30 mm petri
dishes and incubated for 2 weeks and scored for CFC using
established criteria. For cytospin preparation, the hematopoietic
colonies were extracted from methocult cultures and Wright-
Giemsa staining of cytospin preparations was carried out to assess
nuclear and cytoplasmic morphology of the cells. Surface
immunofluorescence of cells extracted from colonies in methyl-
cellulose was assessed by staining with anti-CD33 and anti-CD45
antibodies directly conjugated with Phycoerythrin after adjusting
for non-specific antibody binding with appropriate isotype control
(Immunotech, Cat# IM1179 (CD33-PE), IM2078 (CD45-PE) and
IM0670 (IgG1-PE)). Data was acquired on FACS Canto (Becton-
Dickinson) and analysed with DIVA software.
Quantitative RT-PCR
Total RNA was extracted from the cells by homogenization in
Trizol Reagent (Invitrogen cat# 15596-026) and extraction with
chloroform followed by precipitation with iso-propyl alcohol as per
the manufacturer’s instructions. The RNA was then purified with
RNeasy columns (Qiagen, cat# 74104) with an on-column
DNaseI digestion step, as per the manufacturer’s instructions.
Purified RNA was used to generate cDNA using Superscript-III
reverse transcriptase (Invitrogen, cat# 18080-093) as per the
manufacturer’s instructions. 10 ng of cDNA was used per PCR
reaction using iQ-SYBR-green master mix (BioRad, cat# 170-
8882) or Power SYBR Green PCR Master Mix (Applied
Biosystems, cat# 4368702) in triplicate. Relative expression of
various marker genes was determined by delta-delta Ct method
with Pfaffl modification[64] and with the expression of beta-actin
as internal housekeeping reference. The primer sequences are
listed in Supplementary Table S1 and were derived from the
MGH Primerbank [65]. Specificity of amplification was assured
with analysis of dissociation curves of all reactions. PCR was also
performed with ‘‘no reverse transcriptase’’ control for all samples
and no amplification was detected in these controls.
Immunofluorescence microscopy
hEB were suspended in 50uL of HF (Hank’s Balanced Salt
Solution [Invitrogen, cat# 14175-103]+2% FBS) in an microcen-
trifuge tube, to which 100 mL of Intraprep Reagent 1 (Beckman
Coulter, cat# IM2389 ) was added, and incubated on a rocker table
at 37uC overnight. The next day they were allowed to settle, and
washed 56on a rocker table with 1.5 mL of HF+4%BSA, changing
washeveryhour.Theywerethenresuspendedin100uLofIntraprep
Reagent 2 (Beckman Coulter, cat# IM2389) and 5 uL of 4%BSA,
in the presence of the desired primary antibody, and incubated on a
rocker table at 37uC overnight. They were then again washed 56on
a rocker table with 1.5 mL of HF+4%BSA, changing wash every
hour, and resuspended in 100 uL HF with 5 mL of 4%BSA in the
presence of the desired secondary antibody conjugated to one of
Alexa-488, -546, or -647 (Invitrogen), with Hoechst 33342 dye
(Sigma-Aldrich, cat# B2261) or Alexa-350 conjugated phalloidin
(Invitrogen, cat# A2281) if desired. After incubating on a rocker
table at 37uCovernighttheywereagainwashed56on a rocker table
with 1.5 mL of HF+4%BSA, changing wash every hour. For
imaging, the hEB were then dispensed onto a microscope slide
suspended in HF, inside a 1 mm silicone rubber gasket (Sigma-
Aldrich, cat# S6560), and covered with a coverslip. They were then
imaged through the coverslip using epifluorescenceorlaser-scanning
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hyde for10 minutesat37uC,washed 36inPBS,permeabilized with
100% methanol for 3 minutes at room temperature, washed 36in
PBS, and blocked overnight at 4uC in PBS with 10% FBS. Primary
antibody was added in 10% FBS in PBS, and incubated overnight at
4uC. Cells were then washed 36in PBS, and secondary antibody
was added in PBS with 10% FBS. They were then incubated for
2 hours at room temperature, washed 36in PBS, and imaged in
PBS.
Generation of micro-textured surfaces
Silicon master molds were generated by the Canadian
Microsystems Consortium (http://www.cmc.ca/). Briefly, wafers
of 1-0-0 crystalline silicon were coated with a silicon nitride layer,
which was then selectively removed where micro-wells were to be
formed, and the wafer was then anisotropically etched to generate
arrays of square-pyramidal pits. After subsequent removal of the
remaining silicon nitride layer, the wafer was used as a template
for replica molding in poly(dimethylsiloxane). The wafer was
washed with a 5% solution of Pluronic-F127 (Sigma-Aldrich, cat#
P2443) in water to act as a release agent, drained, and allowed to
air dry. Sylgard-184 (Dow Corning) was combined with the curing
agent and de-gassed as per the manufacturer’s instructions, and
then poured over the wafer and allowed to cure for 3 hours at
70uC, or overnight at 37uC to generate the negative cast. This
process was then repeated to using the negative cast as a template,
to generate the positive cast containing the micro-wells.
Supporting Information
Figure S1 Early embryogenesis is a highly ordered process. After
fertilization, the egg (A) undergoes several rounds of cell division to
give rise to the morula (B). A radial round of cell division then
gives rise to (C) the spatially separate trophectoderm and inner cell
mass (ICM). This is followed by (D) the formation of a cavity - the
blastocoel - within the structure, now known as a blastocyst. The
(E) primitive endoderm then develops at the blastocoelic surface of
the ICM, and migrates out across the inner surface of the
blastocoel. This then differentiates to the parietal endoderm,
where it overlies the trophectoderm, and the visceral endoderm
(VE), where it overlies the ICM. As the VE lays down a basement
membrane at the VE-ICM interface, the ICM polarizes and gives
rise to a pluripotent epithelium known as the epiblast (F). This
same process is also depicted as a cell differentiation hierarchy (G),
where the epiblast then goes on to give rise to the entire developing
organism.
Found at: doi:10.1371/journal.pone.0001565.s001 (0.27 MB TIF)
Table S1 Quantitative RT-PCR primer sequences
Found at: doi:10.1371/journal.pone.0001565.s002 (0.08 MB
DOC)
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